FGF23 and chronic kidney disease: Elevated circulating levels of FGF23 were associated with vascular dysfunction, atherosclerotic burden and left ventricular hyperthrophy in CKD patients [32], [33], and FGF23 directly induced hypertrophy of cultured cardiomyocytes [9].